Shanghai Henlius Biotech Inc Class H (SEHK:2696)

APAC company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - 2696

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - 2696

  • Market CapHKD0.000m
  • SymbolSEHK:2696
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCNE100003N76

Company Profile

Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and innovative biologics for patients with a focus on oncology and autoimmune diseases. The company operates in Mainland China and Overseas. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.

Latest 2696 news

Currently there for this company. Visit our news hub for other news .